Industry
Pharma & Life Sciences
Capital-intensive, heavily regulated and export-driven — we support pharma and life-sciences companies on transfer pricing, M&A, R&D incentives and assurance.
The challenge
Sector challenges
- Transfer pricing on API, formulations and licensing
- Cross-border M&A and out-licensing structures
- Customs, FTP and export incentives
- Quality-of-earnings rigour for investors and acquirers
Our response
How ADA helps
Transfer pricing & DTAA advisory
M&A, due diligence & valuation
Indirect tax, customs & FTP
Statutory & internal audit
Free resource
A head start for pharma & life sciences
PDFFree download
Mauritius vs Singapore vs UAE Holding Comparison
FAQ
Pharma & Life Sciences — frequently asked questions
Explore more
Relevant practices
International Tax & Transfer PricingDTAA, BEPS, Pillar 2 and TP — one team, end to end.M&A, Valuation & Transaction AdvisoryDeal advisory, due diligence and IBBI-registered valuation.Indirect Tax / GSTGST, customs and trade — registration to refunds to litigation.Audit & AssuranceStatutory, internal, forensic and ESG assurance — listed-company grade.Global Entity Setup & International ExpansionIndia-entry and outbound set-up across US, UK, UAE, Singapore.
Work with ADA
Work with ADA on pharma & life sciences
Capital-intensive, heavily regulated and export-driven — we support pharma and life-sciences companies on transfer pricing, M&A, R&D incentives and assurance.